Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Biogen Inc. buy Canaccord Genuity Group Inc.

Biogen Inc.
Start price
€157.60
01.04.26 / 50%
Target price
€211.80
01.04.27
Performance (%)
15.04%
Price
€181.30
14.08.26
Summary
This prediction is currently active. The BUY prediction by Canaccord_Genuity_Gr currently has a performance of 15.04%. This prediction currently runs until 01.04.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Biogen Inc. 0.789% 0.789%
iShares Core DAX® 0,44 % 5,64 %
iShares Nasdaq 100 1,06 % 0,28 %
iShares Nikkei 225® 1,77 % 0,41 %
iShares S&P 500 0,37 % 1,92 %

Comments by Canaccord_Genuity_Gr for this prediction

In the thread Biogen Inc. diskutieren
Prediction Buy
Perf. (%) 15.04%
Target price 211.803
Change
Ends at 01.04.27

Biogen (BIIB) had its price target raised by Canaccord Genuity Group Inc. from $230.00 to $245.00. They now have a "buy" rating on the stock.
Ratings data for BIIB provided by MarketBeat

Canaccord Genuity Group Inc. 
0
Report Share
01.04.26